All News

It’s time to smile and give thanks as people can start to emerge from their bunkers to rejoin society now that there are multiple COVID-19 vaccines, writes one cancer survivor.

In clinical trials, Opdivo in combination with chemotherapy improved overall survival and progression-free survival compared to chemotherapy alone.

After enduring an extensive treatment of 60 chemotherapy infusions, a patient with metastatic breast cancer has developed a superpower — an extreme sense of smell.

Fertility treatments led to a cancer diagnosis but also opened the door to adoption and a new view on life.

Patients with this liver cancer subtype do not need to be hospitalized to receive this treatment and, according to the agent’s manufacturer, Boston Scientific, can typically receive the therapy in approximately an hour during an outpatient procedure.

FDA approval of immunotherapies and BRAF/MEK inhibitors may have impacted overall survival, with a change from seven months between 2010 and 2014 to 13 months between 2015 and 2019.

Life is like a book, writes this cancer survivor. And people shouldn’t be afraid to turn the page to see what’s on the other side, she says.

From the first COVID-19 vaccine doses becoming available for patients and their caregivers at a cancer center in Texas to community police officers delivering food to families impacted by cancer in Philadelphia, here’s what’s happening in the cancer landscape this week.

The HPV vaccine has been shown to help prevent cervical cancer, but what if you didn’t get the vaccine in time to prevent the disease?

Postponing tests or doctor visits during the pandemic may increase women’s risk of cancer.

Why do some survive cancer, while others don’t? And why do those who survive often feel the aches of survivor’s guilt? Here, a survivor shares how she learned to cope.

In this episode of the “CURE® Talks Cancer” podcast, we’re honoring Multiple Myeloma Awareness Month by speaking with Dr. Andrew Yee, about the signs and symptoms of this rare form of cancer, what the current treatment paradigm looks like and what advice he has for newly diagnosed patients.

An expert discusses the treatment options that patients with early relapse myeloma have to treat their recurrent disease, which often follows a cyclical pattern.

Of note, estimates show that there are more than 25,000 patients undergoing allogeneic hematopoietic cell transplantations throughout the United States and beyond. Recent study results show that these patients may be at a higher risk for de novo atrial fibrillation.

Genomic testing has allowed patients to receive more specific drugs that target mutations in their tumors.

A caregiver crosses her fingers that those who love her can have patience as she heals from the trauma of her experiences.

As more is learned about the biology of endometrial cancer, new treatment possibilities emerge.

Increasing healthy eating habits and exercise is important in patients with breast cancer, according to an expert from Mass General Cancer Center.

Data from a recent study found that while the risk of developing cancer is 1.74 times greater for individuals born with major birth defects, that risk is highest in childhood but decreases slightly after age 20.

As the incidence of GI cancer creeps up among younger patients, so does the question of why.

A cancer survivor encourages other patients and survivors to talk more about their thoughts as it may help ease their fears and concerns and help them accept their “new normal.”

How should fertility preservation be addressed in patients who may not be thinking about having children yet?

An expert discusses the potential that several novel therapies hold in treating metastatic breast cancer, including PARP inhibitors, immunotherapy and antibody drug conjugates. Each therapy type has an FDA-approved option to potentially provide patients with better outcomes and quality of life.

In honor of Kidney Cancer Awareness Month, CURE® compiled some recent kidney cancer news and updates patients may have missed.

On social media, CURE® recently asked its readers to share who they have turned to for emotional support during their cancer journey.

A four-time cancer survivor writes a personal letter to her future doctors. She urges doctors to see her and not her diagnosis.

The FDA’s fast track designation to poziotinib for use in previously treated patients with non-small cell lung cancer whose disease harbors a certain genetic mutation, may open the doors to an accelerated approval.

In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.